Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy
Open Access
- 8 December 2009
- Vol. 116 (3), 616-624
- https://doi.org/10.1002/cncr.24768
Abstract
BACKGROUND: Sarcomatoid features in renal cell carcinoma may represent an aggressive subclone arising from the primary tumor. The patterns of metastases for these tumors were evaluated to determine if sarcomatoid features were retained at metastasis and whether the percentage of sarcomatoid features in the primary tumor influenced spread. METHODS: All patients with sarcomatoid features found at nephrectomy with synchronous or metachronous resection of metastases were evaluated. The histology, grade, and percentage of sarcomatoid features in the primary and metastatic site were recorded. The association between percentage of sarcomatoid features, grade, histology, and pattern of metastases was evaluated. RESULTS: Thirty‐two patients were identified with sarcomatoid features and resected metastases. Fifty‐two metastatic sites were evaluated. A single histologic appearance (sarcomatoid or carcinomatoid) was present in 50 of 52 sites (96%). Thirty sites (58%) demonstrated only a sarcomatoid pattern, whereas 20 (38%) contained only a carcinoma pattern. Histology and carcinoma grade did not influence metastatic pattern; however, greater percentage of sarcomatoid features was associated with the presence of distant sarcomatoid histology. A cutoff of 30% sarcomatoid features in the primary tumor was useful in predicting systemic sarcomatoid histology. CONCLUSIONS: Sarcomatoid elements are frequently observed in the metastases of primary tumors with sarcomatoid features, and these metastases generally contain a solitary pattern supporting the subclone hypothesis. However, both components can metastasize in the same patient. The percentage of sarcomatoid features influences the pattern of spread, and patients with >30% sarcomatoid features in the primary tumor frequently have distant sarcomatoid histology. This cutpoint may be helpful for inclusion criteria for future clinical trials. Cancer 2010. © 2009 American Cancer Society.Keywords
This publication has 26 references indexed in Scilit:
- Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted TherapyJournal of Clinical Oncology, 2009
- Immunohistochemical Expression of Hypoxia Inducible Factor-1α and its Downstream Molecules in Sarcomatoid Renal Cell CarcinomaJournal of Urology, 2007
- Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinomaJournal of Surgical Oncology, 2006
- Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformationCancer, 2005
- Cancer, 2004
- Sarcomatoid Renal Cell CarcinomaThe American Journal of Surgical Pathology, 2004
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinomaCancer, 2003
- Doxorubicin and Ifosfamide in Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Phase II Study of the Genitourinary Group of the French Federation of Cancer CentersJournal of Urology, 2002
- Cell proliferative activity and expression of cell‐cell adhesion factors (E‐cadherin, α‐, β‐, and γ‐catenin, and p120) in sarcomatoid renal cell carcinomaJournal of Surgical Oncology, 2001
- Sarcomatoid Differentiation in Renal Cell CarcinomaThe American Journal of Surgical Pathology, 2001